Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
ACS Med Chem Lett ; 3(1): 15-19, 2012 Jan 12.
Article in English | MEDLINE | ID: mdl-22754607

ABSTRACT

We report the design and synthesis of novel FTPA-triazole compounds as potent inhibitors of isoprenylcysteine carboxyl methyltransferase (Icmt), through a focus on thioether and isoprenoid mimetics. These mimetics were coupled utilizing a copper-assisted cycloaddition to assemble the potential inhibitors. Using the resulting triazole from the coupling as an isoprenyl mimetic resulted in the biphenyl substituted FTPA triazole 10n. This lipid-modified analog is a potent inhibitor of Icmt (IC(50) = 0.8 ± 0.1 µM; calculated K(i) = 0.4 µM).

2.
Biochem Biophys Res Commun ; 423(1): 98-103, 2012 Jun 22.
Article in English | MEDLINE | ID: mdl-22634004

ABSTRACT

Isoprenylcysteine carboxyl methyltransferases (Icmts) are a class of integral membrane protein methyltransferases localized to the endoplasmic reticulum (ER) membrane in eukaryotes. The Icmts from human (hIcmt) and Saccharomyces cerevisiae (Ste14p) catalyze the α-carboxyl methyl esterification step in the post-translational processing of CaaX proteins, including the yeast a-factor mating pheromones and both human and yeast Ras proteins. Herein, we evaluated synthetic analogs of two well-characterized Icmt substrates, N-acetyl-S-farnesyl-L-cysteine (AFC) and the yeast a-factor peptide mating pheromone, that contain photoactive benzophenone moieties in either the lipid or peptide portion of the molecule. The AFC based-compounds were substrates for both hIcmt and Ste14p, whereas the a-factor analogs were only substrates for Ste14p. However, the a-factor analogs were found to be micromolar inhibitors of hIcmt. Together, these data suggest that the Icmt substrate binding site is dependent upon features in both the isoprenyl moiety and upstream amino acid composition. Furthermore, these data suggest that hIcmt and Ste14p have overlapping, yet distinct, substrate specificities. Photocrosslinking and neutravidin-agarose capture experiments with these analogs revealed that both hIcmt and Ste14p were specifically photolabeled to varying degrees with all of the compounds tested. Our data suggest that these analogs will be useful for the future identification of the Icmt substrate binding sites.


Subject(s)
Acetylcysteine/analogs & derivatives , Peptides/chemistry , Protein Methyltransferases/antagonists & inhibitors , Protein Methyltransferases/chemistry , Saccharomyces cerevisiae/enzymology , Acetylcysteine/chemistry , Benzophenones/chemistry , Binding Sites , Biotinylation , Enzyme Inhibitors/chemistry , Humans , Mating Factor , Photoaffinity Labels/chemistry , Substrate Specificity
3.
Bioorg Med Chem ; 20(1): 283-95, 2012 Jan 01.
Article in English | MEDLINE | ID: mdl-22142613

ABSTRACT

Human protein isoprenylcysteine carboxyl methyltransferase (hIcmt) is the enzyme responsible for the α-carboxyl methylation of the C-terminal isoprenylated cysteine of CaaX proteins, including Ras proteins. This specific posttranslational methylation event has been shown to be important for cellular transformation by oncogenic Ras isoforms. This finding led to interest in hIcmt inhibitors as potential anti-cancer agents. Previous analog studies based on N-acetyl-S-farnesylcysteine identified two prenylcysteine-based low micromolar inhibitors (1a and 1b) of hIcmt, each bearing a phenoxyphenyl amide modification. In this study, a focused library of analogs of 1a and 1b was synthesized and screened versus hIcmt, delineating structural features important for inhibition. Kinetic characterization of the most potent analogs 1a and 1b established that both inhibitors exhibited mixed-mode inhibition and that the competitive component predominated. Using the Cheng-Prusoff method, the K(i) values were determined from the IC(50) values. Analog 1a has a K(IC) of 1.4±0.2µM and a K(IU) of 4.8±0.5µM while 1b has a K(IC) of 0.5±0.07µM and a K(IU) of 1.9±0.2µM. Cellular evaluation of 1b revealed that it alters the subcellular localization of GFP-KRas, and also inhibits both Ras activation and Erk phosphorylation in Jurkat cells.


Subject(s)
Amides/chemistry , Cysteine/analogs & derivatives , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Protein Methyltransferases/antagonists & inhibitors , Amides/chemical synthesis , Amides/pharmacology , Cysteine/chemistry , Enzyme Activation/drug effects , Enzyme Inhibitors/chemical synthesis , Humans , Jurkat Cells , Kinetics , Phosphorylation , Protein Methyltransferases/metabolism , Structure-Activity Relationship , ras Proteins/metabolism
4.
Bioorg Med Chem Lett ; 21(18): 5616-9, 2011 Sep 15.
Article in English | MEDLINE | ID: mdl-21782433

ABSTRACT

Inhibition of isoprenylcysteine carboxyl methyltransferase (Icmt) offers a promising strategy for K-Ras driven cancers. We describe the synthesis and inhibitory activity of substrate-based analogs derived from several novel scaffolds. Modifications of both the prenyl group and thioether of N-acetyl-S-farnesyl-L-cysteine (AFC), a substrate for human Icmt (hIcmt), have resulted in low micromolar inhibitors of Icmt and have given insights into the nature of the prenyl binding site of hIcmt.


Subject(s)
Cysteine/analogs & derivatives , Enzyme Inhibitors/pharmacology , Lipids/chemistry , Protein Methyltransferases/antagonists & inhibitors , Sulfur/chemistry , Cysteine/chemical synthesis , Cysteine/chemistry , Cysteine/pharmacology , Dose-Response Relationship, Drug , Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/chemistry , Humans , Molecular Structure , Protein Methyltransferases/metabolism , Stereoisomerism , Structure-Activity Relationship
5.
Bioorg Med Chem Lett ; 21(9): 2616-20, 2011 May 01.
Article in English | MEDLINE | ID: mdl-21334890

ABSTRACT

Human isoprenylcysteine carboxyl methyltransferase (hIcmt) is a promising anticancer target as it is important for the post-translational modification of oncogenic Ras proteins. We herein report the synthesis and biochemical activity of 41 farnesyl-cysteine based analogs versus hIcmt. We have demonstrated that the amide linkage of a hIcmt substrate can be replaced by a sulfonamide bond to achieve hIcmt inhibition. The most potent sulfonamide-modified farnesyl cysteine analog was 6ag with an IC(50) of 8.8±0.5 µM for hIcmt.


Subject(s)
Cysteine/analogs & derivatives , Enzyme Activation/drug effects , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Protein Methyltransferases/antagonists & inhibitors , Binding Sites , Cysteine/chemical synthesis , Cysteine/chemistry , Cysteine/pharmacology , Humans , Inhibitory Concentration 50 , Molecular Structure , Protein Processing, Post-Translational
6.
J Biol Chem ; 285(18): 13380-7, 2010 Apr 30.
Article in English | MEDLINE | ID: mdl-20202940

ABSTRACT

The isoprenylcysteine carboxyl methyltransferase (Icmt) from Saccharomyces cerevisiae, also designated Ste14p, is a 26-kDa integral membrane protein that contains six transmembrane spanning segments. This protein is localized to the endoplasmic reticulum membrane where it performs the methylation step of the CAAX post-translational processing pathway. Sequence analysis reveals a putative GXXXG dimerization motif located in transmembrane 1 of Ste14p, but it is not known whether Ste14p forms or functions as a dimer or higher order oligomer. We determined that Ste14p predominantly formed a homodimer in the presence of the cross-linking agent, bis-sulfosuccinimidyl suberate. Wild-type untagged Ste14p also co-immunoprecipitated and co-purified with N-terminal-tagged His(10)-myc(3)-Ste14p (His-Ste14p). Furthermore, enzymatically inactive His-Ste14p variants L81F and E213Q both exerted a dominant-negative effect on methyltransferase activity when co-expressed and co-purified with untagged wild-type Ste14p. Together, these data, although indirect, suggest that Ste14p forms and functions as a homodimer or perhaps a higher oligomeric species.


Subject(s)
Endoplasmic Reticulum/enzymology , Protein Methyltransferases/metabolism , Protein Multimerization/physiology , Saccharomyces cerevisiae Proteins/metabolism , Saccharomyces cerevisiae/enzymology , Amino Acid Motifs , Amino Acid Substitution , Cross-Linking Reagents , Endoplasmic Reticulum/genetics , Mutation, Missense , Protein Methyltransferases/chemistry , Protein Methyltransferases/genetics , Protein Methyltransferases/isolation & purification , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae Proteins/chemistry , Saccharomyces cerevisiae Proteins/genetics , Saccharomyces cerevisiae Proteins/isolation & purification , Succinimides
SELECTION OF CITATIONS
SEARCH DETAIL
...